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functional disability, lower quality of life, and 
shorter life expectancy.1,2 Until today, the diagnosis 
of RA is made based on the criteria from the 1987 
American College of Rheumatology (ACR) in 
which its validity is now being questioned especially 
in regards to diagnosing early RA because the 
rheumatoid factor (RF) is present in only 50% of 
early RA and the radiographic fi ndings showing 
erosion which is characteristic of early RA is found 
in only 13%.3 This limitation should draw our 
attention because diagnosis must be made as early 
as possible in RA management; thereby, enabling 
us to predict erosive RA so that disease-modifying 
antirheumatic drugs could be administered as soon 
and aggressively as possible to slow down the 
process of joint damage.
Some studies reported that in the course of the 
RA disease, RF or anti-cyclic citrullinated peptide 
(anti-CCP) is correlated with the occurrence of a 
more erosive RA. On the other hand, the clinical 
feature of RA seems to be different among various 
ethnic groups and not all RA patients have positive 
RF or anti-CCP. These fi ndings led us to a new 
paradigm: is RA a single disease or has it a particular 
subset related to genetic risk factors?3 Also in its 
natural course, questions remain whether these 
autoantibodies of all the ethnic groups are related 
to joint damage in RA patients so that they could be 
used as the predictors of erosive RA.
The natural course of RA disease is diffi cult 
to predict-which patient has a tendency to have 
progressive disease with persistent infl ammation and 
joint destruction, which patient has slow progress of 
disease, and which patient has fl uctuating disease. 
It is hoped that the understanding of the correlation 
between RF, anti-RA33, and anti-CCP with 28-joint 
Disease Activity Score (DAS28) and joint damage 
in RA patient could be benefi cial for monitoring 
the patient and for administering treatment more 
effectively.
Based on the above points, questions for this 
study were made: do the titers of RF, anti- RA33, 
and anti-CCP have positive correlation with 
DAS28 and joint damage in hand radiograph of RA 
patients?
ABSTRACT
Background:  Rheumatoid arthritis (RA) is a systemic 
chronic infl ammatory disease of the joint that causes 
deformity or disability leading to a decreased function in 
RA patients. According to the 1987 American College 
of Rheumatology, rheumatoid factor (RF) is used as 
one of the diagnostic criteria because until today it 
is still considered as the primary autoantibody in RA 
although it has a lower specifi city than that of anti-
cyclic citrullinated peptide (anti-CCP). Besides RF and 
anti-CCP, anti-RA33 is another autoantibody found. The 
presence of the three autoantibodies in RA patient 
serum is important because it is the starting point of the 
pathogenesis of the autoimmune process in RA.
Methods:  This is a cross-sectional study using 
consecutive sampling. Forty six subjects, all suffering 
from RA, were recruited for this study. All of them were 
tested for RF, anti-CCP, anti-RA33 titers using enzyme-
linked immunosorbent assay (ELISA) method and had 
their hand radiograph taken to obtain the Sharp score 
to evaluate joint damage. During this study, 28-joint 
Disease Activity Score (DAS28) (4 parameters) was also 
evaluated using erythrocyte sedimentation rate as one of 
the parameters.
Results:  The study found that the correlation between 
the three antibodies and DAS28 was not statistically 
signifi cant: RF (r = 0.200, p = 0.091), anti-CCP (r = 
0.117, p = 0.220), and anti-RA33 (r = 0.126, p = 
0.202). There was a signifi cant correlation between anti-
CCP and the Sharp score (r = 0.300, p = 0.021). The 
correlation between the other two autoantibodies and 
the Sharp score was not statistically signifi cant:
RF (r = 0.194, p = 0.098), anti-RA33 (r = 0.156, p = 0.150).
Conclusion:  There was a signifi cant correlation 
between anti-CCP autoantibody and radiographic hand 
joint damage in RA patients so that it could be used 
as an indicator for occurrence of an erosive or a more 
severe RA.
Rheumatoid arthritis (RA) is one form of systemic 
chronic infl ammatory rheumatic disease in which 
up to this day its etiology has not been fully 
explained yet. The course of RA disease has 
clinical characteristics that result in joint damage, 
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METHODS
This is a cross sectional study using consecutive sampling. 
Forty six subjects, all suffering from RA, were recruited 
for this study. All subjects were tested for their RF titer 
using IMTEC-RF IgM from HUMAN, anti-CCP titer using 
IMTEC-CCP-Antibodies from HUMAN, anti-RA33 titer 
using IMTEC-RA33 antibody from HUMAN using enzyme-
linked immunosorbent assay (ELISA) method and hand 
radiography was performed for calculation of Sharp score to 
evaluate joint damage. During this study evaluation of DAS28 
(4 parameters) using erythrocyte sedimentation rate as one of 
the parameters was conducted.
RESULTS
Of 46 subjects in this study, 40 subjects (87%) were female 
and 6 subjects (13%) were male. The majority, 44 subjects 
(95.7%), were married. Although the subjects in this study 
were RA patients who underwent regular follow-ups at 
the rheumatology clinic at Cipto Mangunkusumo General 
Hospital, Jakarta, they were of various ethnic groups: Javanese 
15 subjects (32.6%), Sundanese 12 subjects (26.1%), Batak 7 
subjects (15.2%), Betawi 3 subjects (6.5%), Minang 3 subjects 
(6.5%), Lampung 2 subjects (4.3%), and 1 subject (2.2%) each 
for the following ethnic: Kalimantan, Malay, and Acehnese.
Mean age of the subjects was 48.61 years old, and if 
categorized in decades: 1 subject (2.2%) was in the 20–30 year 
old age bracket, 8 subjects (17.4%) in 31–40 year bracket, 15 
subjects (32.6%) in 41–50 year bracket, 18 subjects (39.1%) 
in 51–60 year bracket, and 4 subjects (8.7%) in 61–70 year 
bracket. In this study the majority was in the 51–60 age 
bracket.
Disease activity evaluation using DAS28 fi ndings were as 
follows: 13 subjects (28.3%) had high disease activity (DAS28 
>5.1), 19 subjects (41.3%) had moderate disease activity 
(DAS28 3.2–5.1), 8 subjects (17.4%) had low disease activity 
(DAS28 2.6–3.2), and 6 subjects (13%) were in remission 
(DAS28 <2.6).
The outcome of Sharp score used as a dependent variable 
in this study was evaluated by a consultant radiologist. An 
intraobserver reliability analysis was conducted that showed 
the observer intraclass correlation coeffi cient values were 
high: joint narrowing score was 0.9848, erosion score 0.9674, 
and total Sharp score 0.9618. The limitations in this study did 
not allow the evaluation of the Sharp score to be conducted by 
two or three observers.
Other characteristic data such as: clinical signs of pain 
and swelling, visual analog scale (VAS) global health score, 
DAS28 score, duration of disease (months), autoantibodies 
level, and Sharp score based on mean and median values of 
the subjects are elaborated in table 1.
Table 1   Characteristics of subjects 
Characteristics  Mean  (SD) Median
Age, years 048.61  (9.23) 50.0
Number of children 003.25  (2.57) 03.0
BMI, kg/m2 024.60  (3.64) 24.25
Tender joint count 005.41  (6.28) 03.0
Swollen joint count 002.54  (3.67) 00.0
VAS global health score 017.50  (17.76) 10.0
ESR, mm/hr   58.50  (32.10) 52.50
DAS28 score 004.24  (1.37) 04.3
RF titer, IU/mL 057.13  (75.29) 22.77
Anti-CCP titer, IU/mL 828.48  (1264.74) 57.6
Anti-RA33 titer, IU/mL 049.85  (99.83) 07.65
Disease duration, months 055.24  (42.70) 39
Joint narrowing score 005.37  (6.26) 03.0
Bone erosion score 003.50  (4.70) 02.0
Total Sharp score 008.76  (9.62) 05.0
BMI, body mass index; VAS, visual analog scale; ESR, erythrocyte 
sedimentation rate; RA, rheumatoid arthritis; DAS28, 28-joint Disease Activity 
Score; RF, rheumatoid factor; anti-CCP, anti-cyclic citrullinated peptide.
Correlation of RF with DAS28 and joint damage in hand 
radiograph
We found that 19 subjects (41.3%) were RF negative (level 
<15 IU/mL) and 27 subjects (58.7%) were RF positive. Data 
normality test using Kolmogorov-Smirnov method found 
that the RF titer, DAS28, and Sharp score showed abnormal 
distribution so that the bivariate statistical analysis used 
was nonparametric statistical test. The result of Spearman’s 
correlation test between RF titer and DAS28 showed that they 
were not signifi cantly correlated (r = 0.200, p = 0.091). The 
test between RF titer and joint damage in hand radiograph 
using Sharp score also showed that they were not signifi cantly 
correlated (r = 0.194 and p = 0.098).
Correlation of anti-CCP with DAS28 and joint damage in hand 
radiograph
The test of anti-CCP titer found that 20 subjects (43.5%) 
were anti-CCP negative (level ≤25 IU/mL) and 26 subjects 
(56.5%) were anti-CCP positive. Data normality test using 
Kolmogorov-Smirnov method, either for the anti-CCP titer 
or the Sharp score, had an abnormal distribution so that the 
bivariate statistical analysis used was nonparametric statistical 
test. The Spearman’s analysis test outcome showed that the 
correlation between anti-CCP and DAS28 was not signifi cant 
(r = 0.117, p = 0.220), but we found a signifi cant correlation 
between anti-CCP and Sharp score (r = 0.300, p = 0.021). The 
correlation above showed that the higher the anti-CCP titer, 
the more hand joint damage based on the Sharp score found. 
The scatter diagram of the correlation between anti-CCP titer 
and joint damage in hand radiograph based on the Sharp score 
could be seen in fi gure 1.
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Figure 1   Scattered diagram of the correlation between anti-CCP 
titer and hand joint damage.
We also found no signifi cant correlation between anti-CCP 
and bone erosion score both in subjects with disease duration 
of less than 3 years (p = 0.401) and more than 3 years (p = 
0.640).
Correlation of anti-RA33 with DAS28 and joint damage in hand 
radiograph
The outcome of anti-RA33 titer test showed that 32 subjects 
(69.57%) were anti-RA33 negative (level <15 IU/mL) and 14 
subjects (31.43%) were anti-RA33 positive. Data normality 
test using Kolmogorov-Smirnov method showed that the anti-
RA33, DAS28, and Sharp score were of abnormal distribution; 
therefore, a nonparametric statistical test was used for the 
bivariate statistical analysis. The Spearman’s test for the 
correlation between anti-RA33 titer and DAS28 showed that 
the correlation was not signifi cant (r = −0.075, p = 0.311). 
The correlation between anti-RA33 and joint damage in hand 
radiograph using the Sharp score showed that the correlation 
was not statistically signifi cant (r = 0.156, p = 0.150).
DISCUSSION
Rheumatoid factor has been known to be one of the 
autoantibodies that play a role in RA pathogenesis. Rheumatoid 
factor is an autoantibody against Cγ22-Cγ3 interface Fc region 
of the immunoglobulin molecule in which its presence in the 
serum is quite sensitive but not too specifi c. High RF titer in 
the serum is reported to be correlated with the severity of joint 
damage and extra-articular manifestations in RA.4
RA patients are in a state of active infl ammation of the 
joints as a result of the differentiation of CD20-CD28+ plasma 
cells in the synovial fl uid produced by a structure resembling 
the germinal centre of the lymphoid tissue. T cells play an 
important role in stimulating lymphocyte B cells to shift 
from the production of IgM RF to secretion of IgG or IgA 
RF to initiate the immune mechanism in RA. The presence 
of IgM RF is dominant in RA patient serum while IgG and 
IgA are dominant in synovial fl uid. The differences in RF 
isotypes are based on the differences in the molecular shape. 
IgM RF is a pentamer and forms a complex with IgG, IgA 
RF is monomer and polymer, and IgG RF is a monomer and 
could form self-associated complex. IgG RF itself could form 
a large complex that will play a role in RA joint infl ammation 
and IgA RF is more associated with causing bone erosion.4-6 
Knijff-Dutmer et al reported the result of RF test using the 
fl uoroimmunoassay method that showed IgM RF was weakly 
correlated with the Sharp score (r = 0.19) and it seemed that 
IgA RF was more correlated with joint damage based on 
radiography.7 Vallbracht et al reported that the RF isotype 
played a role in the course of RA disease—those with high 
IgA RF titer were more correlated with a more severe disease 
activity and the occurrence of joint damage especially if 
there was a high anti-CCP level.8 A study conducted by De 
Rycke et al found that if RF is combined with the presence of 
shared epitope then it would be correlated with joint damage 
according to the radiographic score progression. The RF titer 
is more independent particularly it is more correlated with the 
occurrence of rheumatoid nodule in RA patients.9
The fact that rituximab treatment signifi cantly affects 
only RA patients with positive RF led to a new insight that 
the pathogenesis of RA with positive RF is different from that 
with negative RF. The genetic study in a group of RF-negative 
RA patients found that there was no shared epitope (SE) allele 
such as that of positive RF.5,6 A study conducted by Bas et 
al found that RA with positive IgM RF was correlated with 
the severity of erosion in joint damage based on the Larsen 
score compared to those in seronegative RA, particularly 
those with a disease duration of >12 years.10 Mewar et al 
reported that subjects with S2 allele (K-R-A-A in position 
71–74) were associated with severe or more erosive RA (p = 
0.0059) and was associated with the high RF titer. Erosive RA 
is affected not only by RF titer level but also the presence SE 
allele.11 Today we know that RA has a particular subset that is 
associated with SE allele that affects the severity of the course 
of RA disease.
This study failed to show statistically signifi cant correlation 
between RF titer with DAS28 and hand joint damage. Some 
subjects were RF seronegative; several literatures mentioned 
genetic analysis of RA seronegative did not have SE allele 
and showed a different pathogenesis from that of RA with 
RF seropositive. There is an assumption that the SE allele 
in polymorphic genes is different in each ethnic group in 
Indonesia; however, whether this could affect the statistical 
signifi cance had not been researched in this study. This 
study used a cross-sectional method so that the titer level 
obtained was only at one point in time and only measured the 
IgM RF which could also affect the statistical signifi cance. 
Further studies comparing the seropositive RA group with 
seronegative RA using other RF isotype and using the cohort 
method is recommended.
In RA, we could fi nd a variety of antibodies against 
structures produced by keratinized epithelial cells which 
include antikeratine antibody, antiperinuclear factor, and 
antifi lagrine antibody. The target molecules of these antibodies 
among others are fi lagrine, vimentine, and other peptides. 
Peptidylarginine deiminase enzyme is in charge of converting 
the arginine epitope to citrulline that has autoantigenic 
characteristic in which individuals who have a genetic risk 
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for RA expresses the citrulline protein fragment through 
the MHC class II T cell molecule. Next, B cell response to 
citrulline antigen forms (anti-CCP) autoantibodies that later 
stimulates the chronic infl ammatory process that is the basis 
of RA pathogenesis.12 Various studies reported that anti-CCP 
has higher specifi ty, which is between 94–96%, compared to 
that of RF. One study conducted by Vallbract et al reported 
that although the three RF isotopes were negative in RA 
patients, anti-CCP could be found positive in 34.4% of them.8 
Various studies found that anti-CCP has high sensitivity and 
specifi city so that if RF is negative, anti-CCP test should be 
next carried out.
Some cohort studies found that anti-CCP in the serum 
is found long before RA is diagnosed; therefore, anti-CCP 
is considered as predictor for the occurrence of RA in the 
future in patients with polyarthritis. For diagnosing RA, anti-
CCP is 20% more sensitive than RF. It is proven that RA 
patients with positive anti-CCP have the associated genetic 
risk factors, among others: human leukocyte antigen shared 
epitope alleles (HLA-SE), protein tyrosine phosphatase 
nonreceptor type 22 (PTPN22), complement component 5-
TNF receptor-associated factor 1 (C5-TRAF1), and TNFα-
induced protein 3-oligodendrocyte lineage transcription factor 
3 (TNFAIP3-OLIG3). The presence of HLA-DRB1*0401 and 
HLA-DRB1*0404 causes increased affi nity of a peptide to 
bind with HLA-DRB1 during the conversion of arginine to 
citrulline. In the next stage, the CD4+ T cell is activated which 
stimulates B cell activation resulting in the production of anti-
CCP and at the end the formation of immune complex that 
triggers the infl ammatory process through the upregulation 
of the proinfl ammatory cytokine. This evidence shows 
that anti-CCP plays a dominant role in the development of 
chronic infl ammation of the joints in RA. RA patients with a 
continuously high positive anti-CCP titer and presence of SE 
allele will likely have joint damage.4-6,12
In this study, the correlation between anti-CCP and DAS28 
was not statistically signifi cant, probably because the anti-CCP 
titer at one point of time was not enough to prove its correlation 
with RA activity. The correlation between anti-CCP and joint 
damage according to the Sharp score was signifi cantly positive 
with a correlation coeffi cient of 0.30. This outcome is in line 
with the subjects of this study who were nonsmokers. A study 
by Mattey et al reported that smoking will elevate anti-CCP 
titer and this also occurs to those who have HLA-DRB1 SE.13
Result of other studies supported our study, among others: 
Avouac et al that reported high specifi city of anti-CCP of 
95–96% in RA and Bas et al, Meyer et al, and Bukhari et al 
that reported anti-CCP had high specifi city (96%) and positive 
subjects were strongly correlated with the occurrence of 
erosive RA whose severity is in line with the duration of RA 
disease.10,14,15 Forslind et al and Syversen et al reported that 
anti-CCP was correlated with radiographic joint damage and 
could be used as an independent predictor for progression and 
radiographic RA damage so that it could be used as an indicator 
for the rheumatologist in clinical practice to determine whether 
a more aggressive treatment is needed.16,17 According to a 
study conducted by Lee et al, 81% of RA patients with erosion 
showed reactive anti-CCP. Liao et al suggested revision of 
the RA diagnostic criteria of the 1987 ACR by including anti-
CCP as one of the criteria to replace rheumatoid nodule. They 
found that the sensitivity was higher at 55% and specifi city 
remained high at 91%.12,18-21
This study could not provide enough evidence to support 
the correlation between anti-RA33 and DAS28 nor joint 
damage of the RA hand according to Sharp score. The anti-
RA33 titer taken was at one point of time and 50% of the 
subjects were negative resulting in an insignifi cant correlation 
in the statistical analysis. Despite this fact, Mediwake et al 
reported an optimistic result in which anti-RA33 could be 
used to differentiate erosive RA from erosive SLE. A further 
study is needed to prove this fact.22
CONCLUSION
The anti-CCP autoantibody is signifi cantly correlated with 
joint damage in hand radiograph of RA patients; therefore, it 
could be used as an indicator for the occurrence of an erosive 
or a more severe RA.
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